Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Acne: It's Everywhere, But Still No Silver Bullet Found

Dr. Suzanne Friedler with Advanced Dermatology Says New Treatments Encouraging; Offers Patient Tips.


News provided by

Advanced Dermatology P.C.

Jun 02, 2020, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Suzanne Friedler
Dr. Suzanne Friedler

NEW YORK, June 2, 2020 /PRNewswire-PRWeb/ -- Acne! It's seemingly everywhere, yet no silver bullet exists to cure it, despite years of research, says dermatologist Suzanne Friedler MD. In fact, more than 50 million people in the United States, including 85 percent of adolescents, have the chronic skin disorder. It is reportedly the reason for some 20 percent of all visits to the dermatologist. And, even the Pharaohs of ancient Egypt experienced it, according to earliest known references to the disease, says Dr. Friedler, a New York physician at Advanced Dermatology, PC and the Center for Laser & Cosmetic Surgery.

"What's encouraging is the number of novel, increasingly effective – and more tolerable – acne medications that have become available during the past few years, including the possibility in the future of a vaccine targeting the bacterial toxin believed responsible for acne," says Dr. Friedler, citing a 2018 study published in the Journal of Investigative Dermatology. In the study, scientists report that a toxin released by Propionibacterium acnes (P. acnes), a common bacterium that lives on the surface of the skin, likely induces the inflammation that causes the characteristic inflammatory lesions of acne including papules, pustules and cysts.

What’s encouraging is the number of novel, increasingly effective – and more tolerable – acne medications that have become available during the past few years, including the possibility in the future of a vaccine targeting the bacterial toxin believed responsible for acne.

Post this

Ongoing scientific work continues to enhance understanding of the disorder and its causes. However, experts generally contend that the onset of acne occurs when keratinocytes (skin cells) and sebum, the oily substance produced by sebaceous glands, plug up the skin's follicles. Hair follicles are narrow canals connected to sebaceous glands. The follicle blockade prevents sebum from rising through pores to the skin's surface. The resulting build-up of oil and cells promotes growth of P. acnes leading to an inflammatory response.

Genetics plays a role in acne. Teenagers are at higher risk for the condition if one or both parents had it. Other causes include hormonal changes in both adolescents and adults, especially adult women who are pregnant or in their premenstrual cycle; certain cosmetic products; skin friction from sports equipment or tight-fitting clothes; diet and even stress, Dr. Friedler explains.

"Acne is neither life-threatening nor contagious, but it is a very visible condition that can leave the patient with both physical and emotional scars," says Dr. Friedler, who advises acne-sufferers to seek the immediate counsel of a dermatologist.

"If acne is left untreated or if a person tries to 'pop' or pick off acne lesions in an effort to improve appearance, the skin can be left with permanent scars," she says. "Hereditary factors also make a person more prone to scarring or to unsightly blotches of skin discoloration after the acne lesions have healed."

In its most severe form, acne conglobata may present with papules, pustules, cysts and nodules in the skin. As the high levels of inflammation begin to clear, patients may be left with depressed or raised scars on the skin.

As for the disorder's impact on mental health, Dr. Friedler points to two 2018 studies – one linking acne to a 63 percent higher risk of depression during the first year of the disease (The British Journal of Dermatology) and another to poor self-image and low self-esteem, affecting quality of life (Plos One). Results of a survey presented at an American Academy of Dermatology (AAD) meeting indicated more than two-thirds of respondents considered someone with acne "unattractive."

AAD physician guidelines for managing acne call for application of topical retinoids, vitamin A derivatives that regulate growth of epithelial skin cells. Retinoids such as tretinoin, aldapalene tazarotene and trifarotene help fight comedones (blackheads and whiteheads) which are the precursors to other acne forms. Along with retinoids, Dr. Friedler prescribes prescription-strength topicals consisting of sodium sulfacetamide, benzoyl peroxide, azelaic acid, dapsone, and various antibiotics, depending on the case. Oral treatments include new generation antibiotics, hormonal therapies and Isotretinoin (Accutane). Research has shown oral contraceptives and spironolactone to be effective in women with hormonal acne. Diet and lifestyle modifications can help as well.

For serious or stubborn cases of acne and to speed it's resolution, patients may require chemical peels, photodynamic (light) therapy or laser therapy. These treatments are also helpful for reduction of post-acne scarring and hyperpigmentation. "The favored approach is one tailored to the severity of the condition, the patient's skin type and color and a person's response and tolerance to specific medications," she says. "There is no one 'best' solution or one-size-fit-all therapy for the condition."

Although acne cannot be wholly prevented since genetics is often involved, Dr. Friedler suggests these tips for minimizing its intensity:

  • Wash the face with a gentle cleanser at least twice a day – morning and evening – and before a workout or strenuous task that causes one to perspire.
  • Avoid irritating the skin with scrubs, buff puffs or harsh astringents.
  • Do not pick, pop or try to scrape off acne pimples and nodules. Allow them to heal naturally or with aid of medications
  • Use an oil free mineral sunscreen with an SPF of 50 or higher
  • Keep hair and hands off the face and avoid hair and facial products -- like mousses, gels and creams -- that contain oil or butter.
  • Keep bedding clean by changing bed sheets and pillowcases frequently.
  • See your dermatologist for a customized skin care routine

Suzanne J. Friedler, M.D. F.A.A.D., is a board-certified fellow of the American Academy of Dermatology, with expertise in many areas of medical and cosmetic dermatology. She has been with Advanced Dermatology PC since 2002.

Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York & New Jersey) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com.

SOURCE Advanced Dermatology P.C.

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.